beta-lactams has been researched along with thapsigargin in 1 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (thapsigargin) | Trials (thapsigargin) | Recent Studies (post-2010) (thapsigargin) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 5,234 | 3 | 918 |
| Protein | Taxonomy | beta-lactams (IC50) | thapsigargin (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cainelli, G; Deana, R; Folda, A; Galletti, P; Giacomini, D; Pavanetto, M; Quintavalla, A; Scutari, G; Zarpellon, A | 1 |
1 trial(s) available for beta-lactams and thapsigargin
| Article | Year |
|---|---|
Inhibitory effect by new monocyclic 4-alkyliden-beta-lactam compounds on human platelet activation.
Topics: beta-Lactams; Blood Platelets; Blood Proteins; Calcium; Carcinogens; Cell Survival; Endoplasmic Reticulum; Enzyme Inhibitors; Humans; Monobactams; Phorbol Esters; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Thapsigargin; Thrombin | 2007 |